eFFECTOR Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
EFTR, EFTRW on Nasdaq
Industry
Pharmaceutical Preparations
Location
142 North Cedros Avenue, Suite B, Solana Beach, California

Insiders trading volume in the past year

eFFECTOR Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Carlyle Group Inc. 10%+ Owner $2.92 M Aug 1, 2022
Jonathan Root Director, 10%+ Owner $2.74 M Dec 2, 2021
Column Group II GP, LP 10%+ Owner $2.61 M Aug 25, 2021
Presidio Management Group X LLC 10%+ Owner $2.49 M Aug 1, 2022
Locust Walk Sponsor, LLC 10%+ Owner $2.46 M Aug 25, 2021
Sr One Capital Management, Llc 10%+ Owner $1.1 M -$369 K -25.1% Nov 27, 2023
Stephen T. Worland Chief Executive Officer, Director $58.9 K May 15, 2024
Caroline M. Loewy Director $5.49 K Jun 13, 2024
Michael Byrnes Chief Financial Officer $5.25 K May 15, 2024
Kristen Harrington-Smith Director Jun 13, 2024
Douglas J. Warner Chief Medical Officer Feb 19, 2024
Mayank Gandhi Chief Business Officer Jan 17, 2023
Brian M. Gallagher Jr. Director Jun 13, 2024
John W. Smither Director Jun 22, 2023
Abingworth LLP 10%+ Owner Oct 6, 2021
Barbara Klencke Director Jun 13, 2024
Christopher B. Ehrlich Director Jun 13, 2024
Laurence Lasky Director Oct 6, 2021
Alana B. McNulty Chief Business Officer Jun 20, 2022
Elizabeth Bhatt Director Jun 13, 2024
Premal Patel Chief Medical Officer Jan 20, 2022

Recent Insider Transactions by Companies or Individuals for eFFECTOR Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership